Lara Shirikjian
Psychiatry · Torrance, CANPI 1609193978
Payments from drug & device makers
Across 2,026 payments — averaging $6229.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3.6M
- AbbVie$1.9M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1.7M
- E.r. Squibb & Sons, L.L.C.$1.4M
- Sumitomo Pharma America, Inc.$1.2M
- Boehringer Ingelheim$798K
- plus $2M from 21 others
Across 22 payments — averaging $292.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$4K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$12,621,353 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Torrance
- Kevin StephanoffTorrance$992K
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.